Vit Vasista

Overview

Vit Vasista received an average of $2M in total compensation, including $453K in salary, at Regenxbio from 2019 to 2021.

Source: SEC filing on April 7, 2022.

Related executives

We found six more executives who work or worked at Regenxbio.

Kenneth Mills

Regenxbio

Chief Executive Officer

Patrick Christmas

Regenxbio

Chief Legal Officer

Curran Simpson

Regenxbio

EVP, Chief Operations and Technology Officer

Olivier Danos

Regenxbio

Chief Scientific Officer

Vittal Vasista

Regenxbio

Chief Financial Officer

Stephen Yoo

Regenxbio

Chief Medical Officer

News

You may also like